Product Program year 2025 Source: CMS Open Payments

Pedmark

Drug Oncology

NDC 73077-010-01

Open in the dashboard

General payments

$33,839

49 payments

Research payments

$0

0 payments

Through program year 2025, $33,839 in general payments and $0 in research payments were reported against Pedmark (Oncology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2025 General $33,839 49

Breakdown

Who paid General payments · program year 2025
  1. Fennec Pharmaceuticals, Inc. $33,839 49 payments
Top recipients General payments · program year 2025
  1. Scott Penney Pediatric Hematology-Oncology · San Antonio, TX $20,480 61% · 20 payments
  2. Leslie Worona Nurse Practitioner, Family · New York, NY $6,236 18% · 7 payments
  3. Ralph Boccia Hematology & Oncology · Bethesda, MD $3,878 11% · 7 payments
  4. Muhammad Sarfraz Nawaz Hematology & Oncology · Indianapolis, IN $767 2% · 1 payment
  5. Muhammad Farooq Medical Oncology · Lakeland, FL $767 2% · 1 payment

The top 5 of 17 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Pediatric Hematology-Oncology Pediatrics $20,480 61% · 1 practitioner
  2. Nurse Practitioner, Family Nurse Practitioner $6,587 20% · 3 practitioners
  3. Hematology & Oncology Internal Medicine $4,645 14% · 2 practitioners
  4. Medical Oncology Internal Medicine $767 2% · 1 practitioner
  5. Nurse Practitioner $415 1% · 2 practitioners

The top 5 of 10 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Texas $20,727 61% · 2 recipients
  2. New York $6,236 18% · 1 recipient
  3. Maryland $4,178 12% · 2 recipients
  4. Florida $1,812 5% · 10 recipients
  5. Indiana $886 3% · 2 recipients

Each share is of general payments naming this product in 2025 where a state was reported.

49 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record